Evidence map›Paper›PMID 36358888›Full record

ReviewCancers2022

The Effects of Patient-Reported Outcome Screening on the Survival of People with Cancer: A Systematic Review and Meta-Analysis.

Caterina Caminiti, Giuseppe Maglietta, Francesca Diodati, Matteo Puntoni, Barbara Marcomini, Silvia Lazzarelli, Carmine Pinto, Francesco Perrone

Abstract readReview
In one paragraph

Review in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Patient-reported outcome measures in penile cancer: a narrative review.International journal of impotence research · 2025
    Review
  11. Article
  12. Exploratory analysis of electronic patient-reported outcomes collection: comparing online and in-clinic modalities in cancer care.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2025
    Article
  13. PatientEClinicalMedicine · 2025
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Using Patient-Related Outcomes Data to Inform About a Novel Exercise Program in Oncology Patients.Journal of cancer education : the official journal of the American Association for Cancer Education · 2025
    Article
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Caterina CaminitiClinical and Epidemiological Research Unit, University Hospital of Parma, 43126 Parma, Italy.ORCID 0000-0002-3196-2435
Giuseppe MagliettaClinical and Epidemiological Research Unit, University Hospital of Parma, 43126 Parma, Italy.ORCID 0000-0003-4497-1872
Francesca DiodatiClinical and Epidemiological Research Unit, University Hospital of Parma, 43126 Parma, Italy.ORCID 0000-0002-6372-225X
Matteo PuntoniClinical and Epidemiological Research Unit, University Hospital of Parma, 43126 Parma, Italy.ORCID 0000-0002-7908-0626
Barbara MarcominiClinical and Epidemiological Research Unit, University Hospital of Parma, 43126 Parma, Italy.
Silvia LazzarelliClinical and Epidemiological Research Unit, University Hospital of Parma, 43126 Parma, Italy.
Carmine PintoMedical Oncology, Comprehensive Cancer Center, Azienda USL-IRCCS Reggio Emilia, 42122 Reggio Emilia, Italy.ORCID 0000-0002-3159-5268
Francesco PerroneClinical Trials Unit, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, 80131 Naples, Italy.ORCID 0000-0002-9738-0526

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study examined the effects of the routine assessment of patient-reported outcomes (PROs) on the overall survival of adult patients with cancer. We included clinical trials and observational studies with a control group that compared PRO monitoring interventions in cancer clinical practice to usual care. The Cochrane risk-of-bias tools were used. In total, six studies were included in the systematic review: two randomized trials, one population-based retrospectively matched cohort study, two pre−post with historical control studies and one non-randomized controlled trial. Half were multicenter, two were conducted in Europe, three were conducted in the USA and was conducted in Canada. Two studies considered any type of cancer, two were restricted to lung cancer and two were restricted to advanced forms of cancer. PRO screening was electronic in four of the six studies. The meta-analysis included all six studies (intervention = 130.094; control = 129.903). The pooled mortality outcome at 1 year was RR = 0.77 (95%CI 0.76−0.78) as determined by the common effect model and RR = 0.82 (95%CI 0.60−1.12; p = 0.16) as determined by the random-effects model. Heterogeneity was statistically significant (I2 = 73%; p < 0.01). The overall risk of bias was rated as moderate in five studies and serious in one study. This meta-analysis seemed to indicate the survival benefits of PRO screening. As routine PRO monitoring is often challenging, more robust evidence regarding the effects of PROs on mortality would support systematic applications.

Indexed as

cancermeta-analysisoverall survivalpatient-reported outcomesymptom monitoringsystematic review

Identifiers

PMID36358888
PMCPMC9657884

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.